JonesTrading analyst Justin Walsh has reiterated their bullish stance on XAIR stock, giving a Buy rating today.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Justin Walsh has given his Buy rating due to a combination of factors, including Beyond Air’s recent financial performance and strategic agreements. The company reported a significant increase in revenue for the first quarter of fiscal year 2026, surpassing both year-over-year and quarter-over-quarter expectations, which indicates strong demand in the U.S. market.
Furthermore, Beyond Air’s strategic partnership with Premier, Inc., a major Group Purchasing Organization, is expected to enhance market penetration and facilitate revenue growth. Additionally, the potential approval of the next-generation LungFit PH device, which is designed to be more user-friendly and versatile, could further drive market adoption and revenue expansion. Despite concerns over the company’s current cash position, these strategic initiatives and product advancements underpin the optimistic outlook for Beyond Air’s financial growth.
In another report released today, Piper Sandler also reiterated a Buy rating on the stock with a $5.00 price target.
Based on the recent corporate insider activity of 9 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of XAIR in relation to earlier this year.